ORTEX Pulse
One-sentence market alerts triggered by data threshold crossings across short interest, cost to borrow, options flow, analyst ratings, and institutional positioning.
ORTEX Pulse
Showing 1051–1100 of 19935.
CNLCNL short interest surges 22% over one week to 0.85% of float, driven by rising availability of shares to borrow now at 2,009% of SI.8 Sept 2026FLGFLG Morgan Stanley upgrades to Overweight, raises price target to $17 from $15—implying 26% upside from current $13.52 level. Short interest creeping higher at 9.04% of float, up 10.8% over past month, though borrow costs remain cheap at 0.43%.8 Sept 2026ZIONZION short interest fell 33.5% over the past month to 3.14% of float, while Morgan Stanley downgraded the stock to Underweight from Overweight at $77 price target on September 8.8 Sept 2026SFNCSFNC short interest climbed 7.7% over the past month to 4.1% of float, even as Morgan Stanley downgraded the stock to Underweight while raising its price target to $26.8 Sept 2026PBPB short interest fell 2.7% in one day to 3.9% of free float, as Morgan Stanley downgraded PB to Underweight from Equal-Weight, maintaining a $80 price target. Short sellers trimmed positions following the negative call.8 Sept 2026EWBCEWBC Morgan Stanley upgrade targets 22% upside; analyst raises rating to Overweight, price target to $160 from $131.8 Sept 2026CUBICUBI short interest hits 6.6% of float as Morgan Stanley downgrades to Underweight, raising price target 1.1% to $89.8 Sept 2026CBCCBC Morgan Stanley downgrade tempers bullish outlook; stock at $32.64.8 Sept 2026CFRCFR Morgan Stanley upgrades to Overweight, raises PT to $200 from $141, signaling 42% upside from current $162.62 level.8 Sept 2026CBSHCBSH Morgan Stanley upgrade lifts target to $76, implying 30% upside from current levels. SI % FF at 5.96%, up 24% in one week, signals growing shorts despite analyst bullish turn.8 Sept 2026CBSHCBSH short interest surges 23.9% in one week to 5.96% of float, driven by rapid share accumulation amid analyst upgrade. Cost to borrow remains benign at 0.49%, while availability plummets 84% to 647.5%, signaling tightening conditions for new shorts.8 Sept 2026OZKOZK short interest stands at 13.7% of free float, down marginally from 13.7% one week ago, as Morgan Stanley downgrades to Underweight with $56 target.8 Sept 2026MTBMTB Morgan Stanley upgrades to Overweight, raises PT 20% to $304 from $253. Stock at $239.84, consensus Hold, short interest 3.1% of float and falling.8 Sept 2026PTONPTON Morgan Stanley downgrades to Underweight, cuts PT 10% to $4.50 — below current $5.40 price. Stock down 18% past month amid high short interest of 14% float.8 Sept 2026SNPSSNPS upgrades to Overweight by Morgan Stanley (Lee Simpson); target price held at $500, consensus Buy. Stock down 5.4% today, 11% this week amid broad software weakness.8 Sept 2026TENBTENB short interest surges 49% in one week to 12.2% of float, highest level since late August, as cost to borrow remains subdued at 0.48%.8 Sept 2026TETE short interest utilization maxes at 100%, lowest availability in 52 weeks at 0.46%—near-zero borrow supply constrains short sellers despite 33% short interest of float.8 Sept 2026FCELFCEL cost to borrow surges 110% over one week to 0.43%, though remains historically low and accessible to short sellers rebuilding positions ahead of earnings.8 Sept 2026DIVODIVO short interest plummets 50% in one week to 0.05% of float, down from elevated August levels as availability surges to 4,892%.8 Sept 2026PJPPJP short interest plummets 37.7% in one week to 0.58% of float, lowest level in months.8 Sept 2026PTFPTF short interest falls 21% over the past week to 1.11% of free float, near multi-month lows as bearish bets unwind on the technology momentum ETF.8 Sept 2026ODFLODFL upgraded to Buy by Citigroup; target lowered to $223 from $231, implying 20% upside from $186 close.8 Sept 2026CHRWCHRW upgrades to Buy from Neutral as Citigroup's Rosa sees value, though lowers price target to $185 from $196—implying 25% upside from current $147.64.8 Sept 2026ABNBABNB upgraded by Raymond James to Outperform with $200 price target, up from Market Perform; stock at $181.94, up 21% in one month amid analyst momentum.8 Sept 2026PHRPHR Raymond James downgrades to Market Perform from Outperform, trimming conviction on healthcare software amid persistent growth headwinds. Stock at $10.94, down 10% over past week.8 Sept 2026PHRPHR put/call ratio plunges to 0.14—lowest in 52 weeks—signaling aggressive call buying as stock trades near $11, well below $13.94 analyst mean target.8 Sept 2026ARTYARTY short interest surges 62% in one week to 1.08% of float, though availability remains ample at 133%.8 Sept 2026INTCINTC Northland upgrades to Outperform, sets $120 price target—25% above current $95.80, citing foundry recovery and AI-driven demand momentum.8 Sept 2026ESSESS downgraded by Mizuho to Neutral from Outperform; price target cut to $295 from $308, implying 5.8% downside from current $278.61 level.8 Sept 2026FDSFDS upgraded to Outperform by William Blair; short interest at 9.5% of float, down 30% over past month.8 Sept 2026ECHOECHO upgraded to Buy by UBS with $150 target, up 18% from prior $127, implying 67% upside to price. Stock trades $89.80 with 18.5% SI of float; high availability (189%) eases short covering risk.8 Sept 2026BHVNBHVN short interest 13.4% of free float; RBC downgrades to Sector Perform, cuts price target to $19 from $23.8 Sept 2026LMTLMT UBS upgrades to Buy with $674 target, up 16% from $581, implying 28% upside to current $525 close after stock fell 11% this month.8 Sept 2026ETNETN UBS upgrades to Buy with $515 target, 14% above current price; analyst sees strong momentum ahead.8 Sept 2026DOCSDOCS downgraded to Hold by Freedom Capital Markets, though analyst raises price target to $27 from $24—implying 2.5% upside from current levels as short interest remains elevated at 12.8% of float.8 Sept 2026ALVALV short interest at 5.7% of float, down 6.1% over one week, as TD Cowen downgrades to Hold with $137 price target, 7.4% below prior estimate.8 Sept 2026HACKHACK utilization surges to 91%, highest since mid-August, as shares available to borrow tighten sharply.8 Sept 2026HACKHACK short interest drops 34% over one week to 0.97% of float, now at lowest level in months as cost to borrow falls to 0.76%.8 Sept 2026ETHETH short interest falls 20% in one week to 1.92% of float, lowest level since late July as cost to borrow drops to 0.84%.8 Sept 2026FPXFPX short interest fell 21.9% over one week to 0.21% of float, near multi-month lows.8 Sept 2026INFQINFQ utilization hits 100%, maxed out for the year—availability plummets 93% in one week to just 1.01%, signaling acute squeeze on short borrow supply.8 Sept 2026ASPIASPI utilization hits 100%, near 52-week peak, as available shares to borrow drop to just 0.9% of short interest—severely constraining new short positions.8 Sept 2026ASPIASPI cost to borrow surges 255% in one week to 1.30%, hitting highest level since late August as short interest remains elevated at 24.6% of float.8 Sept 2026CPERCPER short interest falls 25% in one week to 5.9% of float, driven by copper market rally on Fed rate-cut expectations.8 Sept 2026ENBENB short interest surges 49.5% over one week to 1.43% of float, driven by activist repositioning and elevated cost-to-borrow volatility.8 Sept 2026STST upgrades to Overweight from Equal-Weight at Barclays; price target held at $55. Stock at $43.08, up 5% this week.8 Sept 2026SOUNSOUN short utilization hits 98.19%, near 52-week high of 100%, with zero shares available to borrow—nearly all lendable float exhausted for five consecutive weeks.8 Sept 2026ELMTELMT utilization reaches 92.86%, near the 52-week high of 100%, indicating most available shares to borrow are lent out and making shorts harder to establish.8 Sept 2026ODDODD put-call ratio plummets to 0.43, a -4.16 standard deviations below the 20-day mean of 0.80—lowest level in 52 weeks—signaling extreme bullish options positioning ahead of earnings Sept. 9.8 Sept 2026BBYBBY short interest falls to 6.8% of float, down 19% in a month, as DA Davidson downgrades Best Buy to Neutral with $95 target.8 Sept 2026